EUVIMEDEUVIMED entdecken
Open Access

Expression and significance of ependymin‐related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome

Ren Xiaopang iD, Song Jie, Hao Wanjiao, Liu Man

International Journal of Gynecology & Obstetrics · 2026

DOI: 10.1002/ijgo.70928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Ren Xiaopang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Affiliated Hospital of Hebei University, Baoding, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Neuregulins, Nerve Tissue Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Affiliated Hospital of Hebei University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study investigates the expression of ependymin‐related protein 1 (EPDR1) and neuregulin 4 (NRG4) in the serum of patients with polycystic ovary syndrome (PCOS) and their relationship with glucose and lipid metabolism in order to explore the pathogenesis of PCOS and provide new theoretical basis for its treatment.

Methods

A total of 282 PCOS patients were selected as the experimental group, and 60 healthy women were selected as the control group. The levels of EPDR1 and NRG4 in serum were measured by enzyme‐linked immunosorbent assay (ELISA). Serum levels of follicle‐stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T), estradiol (E 2 ), progesterone (P), and prolactin (PRL) were also measured. All subjects underwent tests for triglycerides (TG), total cholesterol (TC), high‐density lipoprotein cholesterol (HDL‐C), and low‐density lipoprotein cholesterol (LDL‐C) as well as insulin release test (IRT) and oral glucose tolerance test (OGTT). The PCOS group was further divided into obese and non‐obese subgroups based on body mass index (BMI) and into insulin resistance (PCOS‐IR) and non‐insulin resistance (PCOS‐non‐IR) subgroups based on HOMA‐IR values. Further stratification was performed based on BMI and HOMA‐IR to divide the PCOS group into PCOS obese IR, PCOS obese non‐IR, PCOS non‐IR non‐obese, and PCOS‐IR non‐obese subgroups to clarify the relationship between NRG4, EPDR1, and PCOS.

Results

The BMI, waist‐to‐hip ratio (WHR), LH, LH/FSH, T, HOMA‐IR, TC, TG, and LDL‐C levels in the PCOS group were significantly higher than those in the control group, while HDL‐C, EPDR1 and NRG4 levels were significantly lower than those in the control group ( P < 0.05). The HOMA‐IR, BMI, WHR, TC, TG, and LDL‐C levels in the PCOS obese subgroup were significantly higher than those in the non‐obese subgroup, while HDL‐C, NRG4, and EPDR1 levels were significantly lower than those in the non‐obese subgroup ( P < 0.05). The BMI, WHR, TC, TG, and LDL‐C levels in the PCOS‐IR subgroup were significantly higher than those in the PCOS‐non‐IR subgroup, while NRG4 and EPDR1 levels were significantly lower than those in the PCOS‐non‐IR subgroup ( P < 0.05). Multiple linear regression analysis showed that NRG4 was negatively correlated with BMI, IR, T, LH/FSH, TC, and EPDR1 ( P < 0.05); EPDR1 was negatively correlated with BMI, LH/FSH, and TC ( P < 0.05). In the PCOS group, NRG4 was negatively correlated with BMI, IR, LDL‐C, and EPDR1 ( P < 0.05); EPDR1 was negatively correlated with BMI, IR, LH/FSH, TC, and LDL‐C and positively correlated with HDL‐C ( P < 0.05).

Conclusion

Serum levels of EPDR1 and NRG4 were significantly decreased in PCOS patients and showed significant correlations with key metabolic and endocrine parameters (BMI, T, HOMA‐IR, LH/FSH ratio, and lipid profiles). These findings highlight their potential value as diagnostic biomarkers for PCOS, reflecting the associated metabolic disturbances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeNeuregulinsNerve Tissue ProteinsHumansFemaleAdultInsulin ResistanceBody Mass IndexObesityCase-Control StudiesYoung AdultBlood GlucoseLuteinizing HormoneGlucose Tolerance TestTriglyceridesEnzyme-Linked Immunosorbent AssayLipid MetabolismTestosteroneFollicle Stimulating Hormone

Stichwörter der Autor:innen

EPDR1NRG4body mass indexhigh‐density lipoprotein cholesterolinsulin resistancelow‐density lipoprotein cholesterolpolycystic ovary syndrometotal cholesteroltriglycerides

Substanzen

neuregulin-4NeuregulinsNerve Tissue ProteinsBlood GlucoseLuteinizing HormoneTriglyceridesTestosteroneFollicle Stimulating Hormone

Autor:innen und Institutionen

  • Department of Reproductive Medicine, Affiliated Hospital of Hebei University, Baoding, China.

ORCID-Profile: Ren Xiaopang

Förderung

  • Affiliated Hospital of Hebei University

Zitieren

APA

Xiaopang, R., Jie, S., Wanjiao, H., & Man, L. (2026). Expression and significance of ependymin‐related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70928

Vancouver

Xiaopang R, Jie S, Wanjiao H, Man L. Expression and significance of ependymin‐related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70928

BibTeX
@article{Xiaopang2026,
  author = {Xiaopang, Ren and Jie, Song and Wanjiao, Hao and Man, Liu},
  title = {Expression and significance of ependymin‐related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  doi = {10.1002/ijgo.70928}
}
Kostenlos starten →